Bank of Montreal
HRMY icon

Bank of Montreal’s Harmony Biosciences HRMY Stock Holding History

Bank of Montreal’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
7,815
-22,039
-74% -$695K ﹤0.01% 2808
2026
Q1 		$836K Buy
29,854
+2,349
+9% +$77K ﹤0.01% 2139
2025
Q4 		$1.03M Buy
27,505
+14,023
+104% +$461K ﹤0.01% 1959
2025
Q3 		$372K Sell
13,482
-77
-0.6% -$2.65K ﹤0.01% 2421
2025
Q2 		$428K Buy
13,559
+1,729
+15% +$55.6K ﹤0.01% 2364
2025
Q1 		$393K Buy
+11,830
New +$424K ﹤0.01% 2339
2023
Q3 		– Sell
-79,754
Closed -$2.91M – 4000
2023
Q2 		$2.91M Buy
+79,754
New +$2.75M ﹤0.01% 1611
2022
Q2 		– Sell
-6,085
Closed -$307K – 4232
2022
Q1 		$307K Buy
6,085
+165
+3% +$6.73K ﹤0.01% 3171
2021
Q4 		$263K Buy
+5,920
New +$236K ﹤0.01% 2805
2021
Q2 		– Sell
-190
Closed -$5K – 4218
2021
Q1 		$5K Sell
190
-785
-81% -$27.5K ﹤0.01% 4643
2020
Q4 		$35K Buy
+975
New +$39.4K ﹤0.01% 4136

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of Montreal's HRMY Position: Q2 2026 in Review

Bank of Montreal reduced its Harmony Biosciences (HRMY) stake by 74% in Q2 2026, selling an estimated $695K and leaving 7,815 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #2808.

Bank of Montreal first reported a position in HRMY in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.91M in Q2 2023. 301 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Bank of Montreal held 7,815 shares of Harmony Biosciences worth $285K as of Q2 2026.
  • Bank of Montreal sold 22,039 Harmony Biosciences shares in Q2 2026, an estimated $695K.
  • Harmony Biosciences made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2808 holding.
  • Bank of Montreal first reported a position in Harmony Biosciences in Q4 2020 and has held it in 11 quarters since.
  • Bank of Montreal's Harmony Biosciences position peaked at $2.91M in Q2 2023.
  • 301 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.